Fig. 2From: Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial)Illustration of the participant flow through the study. Clinical decision point: patients and caregivers are presented with the standard medical risks associated with STEC infection, the known pros/cons of available treatment options, and the treatment currently recommended due to the study allocation. Research decision point: patients and caregivers can consent to data and biospecimen collectionBack to article page